Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06431347 · ClinicalTrials.gov registry record
Prospective Observational Cohort Study of Transplant and Cell Therapy Candidates and Recipients to Assess Social Determinants of Health
A clinical trial of Transplant and Cell Therapy, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- 2,000
- Enrollment target
- 1
- Study location
NCT06431347: Recruiting study of Transplant and Cell Therapy, sponsored by M.D. Anderson Cancer Center.
NCT06431347 is a study of Transplant and Cell Therapy that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 2,000 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06431347, a study of Transplant and Cell Therapy, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- 2,000 participants
- Enrollment target
- 1
- Study location
Study Summary
To learn more about social and financial factors that may influence outcomes of TCT treatment at MD Anderson.
Conditions Studied
Interventions
- BEHAVIORAL Social Determinants of Health Questionnaire
Study Locations (1)
Texas
- MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2024-06-17 |
| Est. Completion | 2029-06-01 |
What NCT06431347 shows while recruiting
NCT06431347 is an observational study that tracks outcomes without assigning an intervention. Its 2,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 1 condition, with Transplant and Cell Therapy appearing as the primary indexed condition, and to 1 intervention - of which Social Determinants of Health Questionnaire is the first listed.
NCT06431347 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06431347 about?
NCT06431347 is a clinical study titled "Prospective Observational Cohort Study of Transplant and Cell Therapy Candidates and Recipients to Assess Social Determinants of Health". To learn more about social and financial factors that may influence outcomes of TCT treatment at MD Anderson.
What is the current status of trial NCT06431347?
This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2024-06-17. Estimated completion is 2029-06-01.
What conditions does trial NCT06431347 study?
This clinical trial studies the following conditions: Transplant and Cell Therapy.
What interventions are being tested in trial NCT06431347?
The interventions under investigation include: Social Determinants of Health Questionnaire (BEHAVIORAL).
Who is sponsoring clinical trial NCT06431347?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06431347 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001465 · 2,000 participants
Study of the Disease Process of Lymphangioleiomyomatosis
- NCT00001595 · 2,000 participants
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
- NCT00138931 · 2,000 participants
Genetics of Cardiovascular and Neuromuscular Disease
- NCT00288119 · 2,000 participants
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI